^
Contact us  to learn more about
our Premium Content:  News alerts, weekly reports and conference planners
DRUG:

GSK5926371

i
Other names: GSK-5926371, GSK5926371, CMG1A46, 1A46, BR110
Associations
Trials
Company:
Chimagen Biosci, GSK, Zhejiang Hisun
Drug class:
CD20 inhibitor, CD3 agonist, CD19 inhibitor
Related drugs:
Associations
Trials